Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Study of Pioglitazone and Tyrosine Kinase Inhibitors (TKIs) in Chronic Myeloid Leukemia Patients After Failure of a First TKIs Discontinuation Attempt in Order to Prepare a New Stop

NCT02889003 is registered in ClinicalTrials.gov with Versailles Hospital as lead sponsor.

NCT NCT02889003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02889003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Study of Pioglitazone and Tyrosine Kinase Inhibitors (TKIs) in Chronic Myeloid Leukemia Patients After Failure of a First TKIs Discontinuation Attempt in Order to Prepare a New Stop
Lead sponsor
Versailles Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
December 31, 2016
Completion date
December 31, 2028
Enrollment
26 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia (cml)